SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 197 filers reported holding SEATTLE GENETICS INC in Q1 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $209,000 | -85.0% | 1,191 | -95.5% | 0.02% | -67.6% |
Q1 2018 | $1,391,000 | -0.4% | 26,569 | +1.8% | 0.07% | 0.0% |
Q4 2017 | $1,396,000 | +1.9% | 26,087 | +3.6% | 0.07% | -5.3% |
Q3 2017 | $1,370,000 | +0.8% | 25,171 | -4.1% | 0.08% | -2.6% |
Q2 2017 | $1,359,000 | -17.1% | 26,258 | +0.7% | 0.08% | -18.9% |
Q1 2017 | $1,639,000 | +4.9% | 26,081 | -11.9% | 0.10% | -3.1% |
Q4 2016 | $1,562,000 | -21.8% | 29,599 | -19.9% | 0.10% | -23.4% |
Q3 2016 | $1,997,000 | +29.8% | 36,974 | -2.9% | 0.13% | +21.9% |
Q2 2016 | $1,539,000 | +20.4% | 38,087 | +4.6% | 0.10% | +12.9% |
Q1 2016 | $1,278,000 | -24.5% | 36,429 | -3.4% | 0.09% | -27.3% |
Q4 2015 | $1,692,000 | -63.4% | 37,698 | -80.1% | 0.13% | -72.8% |
Q3 2015 | $4,624,000 | +287.6% | 189,816 | +669.9% | 0.47% | +286.1% |
Q2 2015 | $1,193,000 | +92.4% | 24,656 | +40.6% | 0.12% | +79.4% |
Q1 2015 | $620,000 | +117.5% | 17,532 | +97.5% | 0.07% | +83.8% |
Q4 2014 | $285,000 | – | 8,875 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |